Gene · 4200
Papers3,297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,297
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs. | Front Endocrinol (Lausanne) | 2022 | 36457557 | PubTator, text mining | PubMed |
| Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance. | Front Endocrinol (Lausanne) | 2022 | 36452319 | PubTator, text mining | PubMed |
| Impact of ATP-citrate lyase catalytic activity and serine 455 phosphorylation on histone acetylation and inflammatory responses in human monocytic THP-1 cells. | Front Immunol | 2022 | 36439127 | PubTator, text mining | PubMed |
| Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4+ regulatory T cells. | Sci Rep | 2022 | 36434024 | PubTator, text mining | PubMed |
| Solute carrier transporter disease and developmental and epileptic encephalopathy. | Front Neurol | 2022 | 36419532 | PubTator, text mining | PubMed |
| How to improve information technology strategic planning effectiveness using balanced scorecard, risk and maturity analysis, case study health information technology? A qualitative study. | Health Sci Rep | 2022 | 36415564 | PubTator, text mining | PubMed |
| Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction. | Elife | 2022 | 36409067 | PubTator, text mining | PubMed |
| Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation. | Front Immunol | 2022 | 36405760 | PubTator, text mining | PubMed |
| Elongator promotes neuritogenesis via regulation of tau stability through acly activity. | Front Cell Dev Biol | 2022 | 36393857 | PubTator, text mining | PubMed |
| AAA+ proteases: the first line of defense against mitochondrial damage. | PeerJ | 2022 | 36389399 | PubTator, text mining | PubMed |
| Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis. | Cancer Res Commun | 2022 | 36388465 | PubTator, text mining | PubMed |
| Effect of short-term warming and drought on the methanogenic communities in degraded peatlands in Zoige Plateau. | Front Microbiol | 2022 | 36386660 | PubTator, text mining | PubMed |
| 4-phenylbutyric acid-Identity crisis; can it act as a translation inhibitor? | Aging Cell | 2022 | 36373957 | PubTator, text mining | PubMed |
| Amyloid Beta in Aging and Alzheimer's Disease. | Int J Mol Sci | 2022 | 36361714 | PubTator, text mining | PubMed |
| Decoding Diabetes Biomarkers and Related Molecular Mechanisms by Using Machine Learning, Text Mining, and Gene Expression Analysis. | Int J Environ Res Public Health | 2022 | 36360783 | PubTator, text mining | PubMed |
| Vantera Mediated Quantification of Urine Citrate and Creatinine: A New Technology to Assess Risk of Nephrolithiasis. | Diagnostics (Basel) | 2022 | 36359450 | PubTator, text mining | PubMed |
| Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism. | Antioxidants (Basel) | 2022 | 36358574 | PubTator, text mining | PubMed |
| Isotope-Assisted Metabolic Flux Analysis: A Powerful Technique to Gain New Insights into the Human Metabolome in Health and Disease. | Metabolites | 2022 | 36355149 | PubTator, text mining | PubMed |
| Study on the differences in aroma components and formation mechanisms of "Nasmi" melon from different production areas. | Food Sci Nutr | 2022 | 36348797 | PubTator, text mining | PubMed |
| [Congenital hyperinsulinism as a part of Kabuki syndrome]. | Probl Endokrinol (Mosk) | 2022 | 36337023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4200/papers?page=21